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SUMMARY
Community-associated methicillin-resistant S. aureus (CA-MRSA) accounts for a growing
proportion of hospital-onset infections, and colonization is a risk factor. This study aimed to
determine changes in the prevalence of CA-MRSA colonization in paediatric intensive-care units
(ICUs). A total of 495 paediatric patients colonized with MRSA from neonatal, medical, surgical,
and cardiac ICUs between 2001 and 2009 were identiﬁed. Isolates were characterized by spa type,
staphylococcal cassette chromosome (SCC) mec type and the presence of the genes encoding
Panton–Valentine leukocidin (PVL). The proportion of patients colonized with MRSA remained
stable (average 3.2%). The proportion of isolates with spa type 1, SCCmec type IV and PVL
increased over time to maximums in 2009 of 36.1% (P<0.001), 54.2% (P=0.03) and 28.9%
(P=0.003), respectively. Antibiotic susceptibility patterns showed increasing proportions
susceptible to clindamycin, gentamicin, tetracycline and trimethoprim-sulfamethoxazole (P values
<0.001). In conclusion, the proportion of MRSA-colonized children in ICUs with CA-MRSA
increased signiﬁcantly over time.
Key words : Colonization, infection control, intensive-care units, methicillin-resistant
Staphylococcus aureus, paediatrics, staphylococcus.
INTRODUCTION
Staphylococcus aureus is a leading cause of hospital-
onset infections, and the proportion of such infections
caused by methicillin-resistant S. aureus (MRSA) is
increasing in the USA and internationally [1, 2].
Colonization with MRSA is a risk factor for the
development of hospital-onsetMRSA infections [3, 4].
The Society for Healthcare Epidemiology of America
recommends that hospitals implement routine active
surveillance cultures to identify MRSA colonization
for patients at high risk for colonization and hospital-
onset infections [5], which often includes patients in
intensive-care units (ICUs). One goal of identifying
MRSA colonization is to ensure that colonized
patients are cared for using contact precautions to
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minimize the transmission of MRSA, as recom-
mended by the Centers for Disease Control and
Prevention [6].
Although MRSA was once mainly a cause of
nosocomial infections, it is now an important cause
of community-associated infections. Community-
associated MRSA (CA-MRSA) causes severe skin
and soft tissue infections [7], necrotizing pneumonias
[8], and other invasive infections in patients without
healthcare exposures. Colonization is likely to be an
important risk factor for MRSA infections, and in
the USA, MRSA nasal carriage rates in children in
the community range from 0.8% to 2.5% [9–12], al-
though a marked rise from 0.8% to 9.2% over 3 years
was found in children in Nashville, Tennessee [13].
The relationship between CA-MRSA and hospital-
associated (HA)-MRSA infections and speciﬁc strains
of MRSA is complex, but CA-MRSA infections were
initially associated with strains that are genetically
distinct from HA-MRSA [14]. However, recent re-
ports show that genetically typed CA-MRSA strains
are increasingly responsible for hospital-onset infec-
tions [15–20].
Various molecular typing methods can be used
to identify genetically deﬁned CA-MRSA strains.
Pulsed-ﬁeld gel electrophoresis (PFGE) classiﬁes
S. aureus into pulsed ﬁeld types, including USA300,
the most common CA-MRSA strain in the USA
[7, 21]. Sequencing of the short sequence repeat region
of the protein A gene (spa) provides a high level of
discrimination between MRSA strains, comparable
to PFGE [22]. Spa typing also has the advantages
of speed, ease and objective interpretation, making
it a useful tool for hospital investigations [23, 24].
Importantly, the USA300 strain is spa type 1 (Ridom
type t008), thus allowing the use of spa typing to
detect the dominant CA-MRSA genotype [14, 25].
Other phenotypic and genotypic characteristics
of CA-MRSA strains include susceptibility to non-
b-lactam antibiotics and carriage of genes for
staphylococcal cassette chromosome (SCC) mec type
IV and Panton–Valentine leukocidin (PVL) [26].
Recent reports describe an increased prevalence of
CA-MRSA colonization in neonatal ICUs (NICUs)
[25, 27–30]. The purpose of this study was to deter-
mine if the prevalence of MRSA colonization has in-
creased in all paediatric ICUs at Children’s Hospital
Boston (CHB), and whether the proportion of colo-
nizing MRSA that are CA-MRSA strains has in-
creased. Routine active MRSA surveillance cultures
were collected from patients in the ICUs at CHB since
2001. We report the prevalence of MRSA coloniza-
tion, as well as the distribution of spa types, antibiotic
susceptibilities, SCCmec types and proportion of
PVL-positive isolates in colonizing MRSA strains
cultured from children admitted to our paediatric
ICUs from 2001 to 2009.
METHODS
Setting
CHB is a 396-bed quaternary care paediatric hospital
with four ICUs, including a NICU, medical/surgical
ICU (MSICU), and cardiac ICU (CICU), as well as a
medical ICU (MICU) that opened in 2008. In 2001,
the Infection Prevention and Control Program re-
commended that all patients be screened by culture of
the nares for MRSA colonization upon admission to
any ICU, and weekly thereafter during the remainder
of their ICU stay. Patients colonized with MRSA
were placed on contact precautions; no decoloniza-
tion procedures were undertaken routinely. The CHB
Committee on Clinical Investigation approved this
study.
Study design and subjects
We performed a retrospective cohort study of all
patients found to be colonized with MRSA during an
admission to a CHB ICU between 1 January 2001 and
31 December 2009. The prevalence of MRSA coloni-
zation and antibiotic susceptibilities and molecular
proﬁles of isolates were determined. Colonization was
deﬁned as an isolate obtained from a MRSA surveil-
lance culture (nares, skin, throat) or bone marrow
transplant surveillance culture (nares, throat, rectum).
While MRSA surveillance cultures from the nares
of ICU patients were obtained according to infec-
tion control policy, other surveillance cultures were
ordered at the discretion of a treating physician.
Data collection
Microbiology laboratory records were reviewed to
ﬁnd MRSA surveillance and bone marrow transplant
surveillance culture results from patients in ICUs.
Chart reviews were performed to ascertain antibiotic
susceptibilities and patient demographics. To analyse
trends in antibiotic susceptibilities and molecular
characteristics, we included the ﬁrst colonizing
MRSA isolate from each patient cultured during an
ICU admission within the study period.
1984 C. R. Hermos and others
Microbiological methods
Cultures were processed using standard micro-
biological methods [31]. From January 2001 to May
2006, samples were plated on mannitol-salt agar and
5% sheep’s blood agar. From May 2006 onwards,
Chromagar MRSA agar (BD Diagnostic Systems,
USA) was used. Colonies with morphology consistent
with S. aureus were identiﬁed by Gram stain, catalase
test and coagulase test. Isolates were tested for
antibiotic susceptibilities using the Vitek system
(bioMe´rieux, USA), except for susceptibilities for
trimethoprim-sulfamethoxazole (TMP/SMX), which
were performed using the disk diﬀusion method until
this test became available for Vitek. Between October
2002 and November 2003, TMP/SMX susceptibilities
were not performed. D-tests were performed to
detect erythromycin-inducible clindamycin resistance
on 252/255 clindamycin-susceptible, erythromycin-
resistant isolates using standard methods [32], and
isolates with inducible clindamycin resistance were
reported as clindamycin resistant.
Beginning 1 January 2001, the microbiology lab-
oratory began storing the ﬁrst MRSA isolate cultured
from each patient (whether from surveillance or
clinical cultures). If the patient’s stored MRSA isolate
was diﬀerent from his/her ICU MRSA surveillance
culture, we included the stored isolate for molecular
analysis if it was collected f1 month prior to the
positive surveillance culture.
Genomic DNA was puriﬁed from cultures using a
QIAamp DNAMini kit (Qiagen, USA). The presence
of the mecA gene was conﬁrmed by polymerase
chain reaction (PCR) on each isolate. SCCmec typing
was performed by multiplex PCR [33] ; the presence
of PVL-encoding genes (lukS/lukF) was determined
by PCR [34] ; and spa typing was performed by
PCR followed by sequencing of the spa gene with
previously described protocols [24]. The spa gene
PCR product was puriﬁed using a QIAquick PCR
Puriﬁcation kit (Qiagen). Sequences were analysed on
the eGenomics software platform (www.egenomics.
com), which provided a Kreiswirth repeat pattern
and spa type. The Kreiswirth repeat pattern was
then analysed by the Ridom software (spaserver.
ridom.de) to determine the Ridom spa type [23]. All
spa types with a Kreiswirth repeat pattern reported as
‘new’, and Ridom spa types reported as ‘unknown’,
were re-sequenced for conﬁrmation. MRSA strains
with spa type 1 were determined as representing
CA-MRSA.
Statistical analysis
Total and annual prevalences of MRSA colonization
in the ICUs were calculated as the number of patients
with at least one positive result in the given year
divided by the total number of patients screened that
year. Trends in the prevalence of MRSA colonization
and the prevalence of spa types, SCCmec types II
and IV, PVL-encoding genes and speciﬁc antibiotic
susceptibilities of MRSA isolates over time were
determined using the Cochran–Armitage trend test.
Analyses were performed using SAS version 9.1 (SAS
Institute Inc., USA).
RESULTS
Prevalence and demographics of MRSA carriage
From 1 January 2001 to 31 December 2009, 15295
patients were screened for colonization with MRSA,
where each patient was counted once per year,
and 495 (3.2%) were found to be colonized. The
total number of surveillance cultures performed and
yielding MRSA increased each year (Fig. 1). Total
yearly ICU admissions increased by 27% over the
study period, from 4033 to 5104. The proportion of
screened patients who were MRSA colonized did not
change signiﬁcantly over time (P=0.82). Males ac-
counted for 53.1% of all MRSA-colonized children,
and the proportion of males did not change signiﬁ-
cantly over time. The median age of MRSA-colonized
patients was 2 years. Patients aged<1 year, 2–4 years,
5–12 years, 13–18 years and>18 years accounted for
42%, 18%, 19%, 13%, and 8% of MRSA-colonized
patients, respectively. Of colonized children, 116
(23.4%) were NICU patients. The proportion of
patients found to be colonized with MRSA each
year who were aged <1 year decreased over time
(P<0.001), while the proportions in age groups 2–4,
5–12 and 13–18 years, increased over time (P=0.02,
0.03, 0.04 respectively) ; the proportion aged >18
years did not change signiﬁcantly over time.
Antibiotic susceptibility of colonizing MRSA
For susceptibility and molecular analysis, 42 cultures
obtained in subsequent years from previously positive
patients were excluded. Of the remaining 453 MRSA
cultures, two susceptibility panels were not available,
so we reviewed antibiotic susceptibilities of 451
MRSA cultures.
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The susceptibility of colonizing MRSA isolates to
several antibiotics changed signiﬁcantly over time
(Table 1). The proportion of isolates susceptible to
gentamicin, tetracycline and TMP/SMX each in-
creased between 2001 and 2003 and then remained
stable, while susceptibility to clindamycin increased
over the study period. The proportion of isolates
resistant to clindamycin with inducible resistance by
D-test increased signiﬁcantly over the study period.
The proportion of isolates susceptible to erythro-
mycin did not change signiﬁcantly. All isolates were
susceptible to vancomycin.
Molecular analysis and spa typing of colonizing
MRSA
Of the 453 unique isolates, 394 (87.4%) isolates were
available for molecular testing because 59 isolates
were not stored. Six of the 394 isolates tested were
non-surveillance cultures obtained within 1 month of
the surveillance MRSA isolate (three sputum, one
blood, two wound). As expected, all isolates were
positive for the mecA gene. The majority of the
MRSA isolates contained SCCmec type II (54.3%) or
type IV (42.6%). Other SCCmec types identiﬁed in-
cluded type I (n=4, 1.0%) and type VI (n=3, 0.8%);
ﬁve (1.3%) isolates had an indeterminate SCCmec
type. Over the 9-year period, the proportion of
MRSA isolates carrying SCCmec type II decreased
(P=0.06), and the proportion carrying SCCmec type
IV increased (P=0.03), but these trends appear to
begin in 2003, following 2 years in which only a small
number of isolates were available for testing (Fig. 2).
The proportion of MRSA isolates carrying the
PVL-encoding genes increased signiﬁcantly over the
study period (P=0.003) (Fig. 3). The proportion
carrying PVL genes was 21.1% overall and ranged
from 0% in 2003 to 28.9% in 2009.
There were 70 diﬀerent spa types in the 394 isolates
analysed (see Supplementary Table S1 which lists all
the spa types identiﬁed in this cohort). Forty-seven
spa types were each found in a single isolate and
23 spa types were identiﬁed in more than one isolate.
Spa types 2 and 1 were the most common, accounting
for 182 (46.2%) and 85 (21.6%) isolates, respectively
(Table 2). Of all MRSA isolates, the proportion with
spa type 1 increased signiﬁcantly (P<0.001), while the
proportion with spa type 2 remained stable (P=0.21)
and the proportion with other spa types decreased
over the study period (P=0.03). The proportion of
MRSA-colonized patients with spa type 1 increased
signiﬁcantly in the NICU (P=0.03) and MSICU
(P=0.02), and trended towards an increase in the
CICU (P=0.12, data not shown). In 2009 the pro-
portion ofMRSA isolates with spa type 1 in theNICU,
MSICU, CICU and MICU were 27.3%, 33.3%,
31.8% and 52.9%, respectively.
An analysis of the SCCmec type and presence of
the genes for PVL was performed for the speciﬁc spa
types (Table 2). Nearly all spa type 1 isolates were
SCCmec type IV, and most were PVL positive. In
contrast, most spa type 2 isolates had SCCmec type II
and nearly all were PVL negative. The majority of
isolates with spa types other than 1 or 2 were SCCmec
II or IV in roughly equal proportions, and most were
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Fig. 1. Annual number and proportion of intensive-care unit patients colonized with methicillin-resistant Staphylococcus
aureus between 2001 and 2009.
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than 1 or 2, carried the same SCCmec type with the
exception of isolates with spa types 12, 14, 17 and 139
which included isolates with SCCmec type II and IV.
DISCUSSION
The increasing prevalence of MRSA spa type 1 in
patients colonized with MRSA in paediatric ICUs
at CHB indicates that CA-MRSA colonization in-
creased in our study population, and the increased
prevalence of SCCmec type IV, PVL and suscepti-
bility to non-b-lactam antibiotics support this con-
clusion. The increase in prevalence of isolates with
SCCmec type IV and PVL is seen most clearly from
2003 on, preceded by an apparent fall in these
numbers from 2001 and 2002. It is diﬃcult to interpret
the data from 2001 and 2002, as only a small number
of isolates (f15) were available from each of these
years. Compared to a recent survey of adult ICUs,
our paediatric cohort had a lower rate of MRSA colo-
nization overall (3.2% vs. 11%), but a much higher
proportion of colonizing MRSA were CA-MRSA
strains (36.2% in 2009 vs. 12%) [35]. The increasing
prevalence of MRSA spa type 1 is consistent with
other reports that CA-MRSA infection, and in
particular USA300, has become more common in
healthcare settings [15–19, 25, 27–30]. These reports
describe an increasing number of hospital-onset
bloodstream infections [17], surgical site infections
[16], other skin and soft tissue infections [19], and
infections in NICU patients with CA-MRSA strains
[25, 28–30]. MRSA colonization is a precursor for
hospital-onset infection, especially in patients with
central venous catheters and endotracheal tubes,
devices that are often necessary for ICU patients [3, 4].
The increased prevalence of CA-MRSA colonization
might therefore increase the risk for hospital-
onset CA-MRSA infection in the paediatric ICU
population.
The initiation of a MRSA active surveillance
programme for all ICU patients in our hospital in
2001 led to a marked increase in the total number of
patients screened. The number of patients screened
for MRSA increased each year, which is explained not
only by the increase in ICU admissions over the study
period, but also improved adherence to the active
surveillance programme. It is possible that as adher-
ence improved, children without healthcare exposures
were more likely to be screened for MRSA coloniza-
tion, which may contribute the larger proportion of
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that the programme resulted in the identiﬁcation of a
larger number of colonized patients, and a growing
number of patients colonized with CA-MRSA who
very likely would not have been identiﬁed in the
absence of a universal screening programme.
Previous studies have reported that CA-MRSA is
commonly found to colonize and infect infants in
NICUs [25, 27–30]. Our study adds to these ﬁndings
by documenting colonization trends in children
admitted to paediatric medical/surgical and cardiac
ICUs over a 9-year timeframe. Two studies of
NICU settings also described increasing prevalence of
CA-MRSA colonization over time, but these studies
diﬀer from ours in several important ways [25, 30].
First, these studies included MRSA isolates obtained
primarily during outbreak investigations, while our
isolates were obtained from routine active surveil-
lance cultures. Second, while both of these studies
reported total proportions of isolates with PVL and
speciﬁc SCCmec types, we have also documented
increasing prevalence of PVL and SCCmec type IV in
colonizing MRSA isolates over time.
Recently, Milstone et al. reported a prevalence of
MRSA colonization of 6% in children admitted to
90


























Fig. 2. Proportion of methicillin-resistant Staphylococcus aureus isolates from colonized children in intensive-care units
between 2001 and 2009 carrying SCCmec types II and IV.
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Fig. 3. Proportion of methicillin-resistant Staphylococcus aureus isolates from colonized children in intensive-care units
between 2001 and 2009 carrying genes that encode Panton–Valentine leukocidin.
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Table 2. Panton-Valentine leukocidin status and SCCmec types of methicillin-resistant Staphylococcus aureus isolates with spa types 1, 2 and other spa types










































2001 15 1 (6.7) 1 (100) 0 (0) 1 (100) 6 (40.0) 0 (0) 6 (100) 0 (0) 8 (53.3) 1 (12.5) 1 (12.5) 7 (87.5)
2002 13 2 (15.4) 1 (50.0) 0 (0) 2 (100) 5 (38.5) 0 (0) 5 (100) 0 (0) 6* (46.2) 0 (0) 0 (0) 5 (83.3)
2003 25 2 (8.0) 0 (0) 1 (50.0) 1 (50.0) 18 (72.0) 0 (0) 16 (88.9) 2 (11.1) 5 (20.0) 0 (0) 4 (80.0) 1 (20.0)
2004 35 4# (11.4) 4 (100) 0 (0) 3 (75.0) 14 (40.0) 0 (0) 12 (85.7) 2 (14.3) 17$ (48.6) 0 (0) 10 (58.8) 6 (35.3)
2005 25 3 (12.0) 3 (100) 0 (0) 3 (100) 12$ (48.0) 0 (0) 10 (83.3) 1 (8.3) 10# (40.0) 1 (10.0) 3 (30.0) 6 (60.0)
2006 55 10 (18.2) 10 (100) 0 (0) 10 (100) 29 (52.7) 0 (0) 26 (89.7) 3 (10.3) 16· (29.1) 2 (12.5) 5 (31.3) 9 (56.3)
2007 67 16 (23.9) 15 (93.8) 0 (0) 16 (100) 31* (46.3) 0 (0) 28 (90.3) 2 (6.5) 20 (29.9) 0 (0) 13 (65.0) 7 (35.0)
2008 76 17 (22.4) 14 (82.4) 0 (0) 17 (100) 37|| (48.7) 2 (5.4) 29 (78.4) 6 (16.2) 22# (28.9) 5 (22.7) 8 (36.4) 13 (59.1)
2009 83 30 (36.1) 23 (76.7) 0 (0) 30 (100) 30 (36.1) 0 (0) 28 (93.3) 2 (6.7) 23$ (27.7) 1 (4.3) 9 (39.1) 13 (56.5)
Total 394 85 (21.6) 71 (83.5) 1 (1.2) 83 (97.6) 182 (46.2) 2 (1.1) 160 (87.9) 18 (9.9) 127 (32.2) 10 (7.9) 53 (41.7) 67 (52.8)
* One isolate, SCCmec type indeterminate.
# One isolate, SCCmec type 6.
$ One isolate, SCCmec type 1.
· One isolate, SCCmec type 1 and one SCCmec type indeterminate.


























the paediatric ICU at Johns Hopkins Hospital in
Baltimore, Maryland over a 15-month period [36].
Forty (61%) out of 66 MRSA colonizing isolates
were CA-MRSA strains, and healthcare-associated
transmission of CA-MRSA resulted in cases of both
colonization and infection. These authors described
an ICU population with a higher prevalence of
MRSA and CA-MRSA colonization than our cohort,
probably due to high rates in the community [20], and
their study oﬀered several important observations.
First, a substantial reservoir of MRSA-colonized
patients would not have been identiﬁed without
routine active surveillance cultures. Second, paediatric
ICU patients colonized with CA-MRSA were similar
epidemiologically to those harbouring HA-MRSA,
apart from those with HA-MRSA being more likely
to have had a prior ICU admission. While the clinical
impact of CA-MRSA colonization in ICUs remains
unclear, our data and those of Milstone et al. high-
light the importance of both routine surveillance in
paediatric ICUs and an understanding of the chang-
ing epidemiology of MRSA colonization on a local
level.
There are multiple potential sources from which
to acquire MRSA. Colonized patients in our study
may have carried MRSA upon admission or, despite
infection control precautions, may have acquired
MRSA from other patients, healthcare providers or
family members [37]. We did not distinguish patients
who were admitted for MRSA infections. Therefore,
some of the increase in CA-MRSA colonization may
have been due to an increasing number of children
hospitalized with serious or invasive CA-MRSA
infections over the study period [38]. However,
given that we observed the increased proportion of
CA-MRSA in the CICU and NICU, where fewer
admissions for community-onset CA-MRSA infec-
tions are expected, we suspect that CA-MRSA infec-
tions alone cannot explain the signiﬁcant increase in
colonization that we observed. Additionally, reliable
data on recent hospitalizations or transfers were not
available for this retrospective study, so we could not
address any associations between colonization and
recent healthcare exposures.
Our study has other potential limitations. First, al-
though we did not perform PFGE of MRSA isolates,
spa type 1 has been shown to correlate with PFGE
type USA300 [14, 25, 39], the genotype responsible
for most CA-MRSA in the USA. In fact, it has
been reported that spa typing more accurately ident-
iﬁes USA300 strains causing community-associated
infections, and that other USA300 strains with a
diﬀerent spa type (type 24) more often cause
healthcare-associated infections [39]. Second, this is
an observational study from a single quaternary care
hospital, and therefore may not be generalizable to
all facilities. Other reports suggest that CA-MRSA
colonization in hospitalized patients is prevalent in
other urban areas [16, 17, 19, 25], although prevalence
is likely to vary, and it is important for healthcare
providers to be aware of local epidemiological trends.
Third, in most cases, we only had molecular data on
the ﬁrst MRSA strain isolated from each patient.
Many patients had repeat admissions and positive
surveillance cultures on subsequent ICU admissions,
and we could not determine if these patients retained
the same MRSA strain or acquired new strains,
because only the ﬁrst isolate of MRSA from each
patient was stored.
Since the implementation of active surveillance for
MRSA colonization in 2001, we have not experienced
an outbreak of MRSA infection in our paediatric
ICUs. Between 2001 and 2009 there was an increase in
the number of colonized patients identiﬁed, but no
increase in the overall prevalence of MRSA coloni-
zation. Current evidence about the eﬃcacy of routine
surveillance for MRSA and the institution of contact
precautions in reducing the frequency of hospital-
onset MRSA colonization and infection in adult
institutions is not conclusive [40, 41]. However, Geva
et al. found that in a NICU setting, identiﬁcation
of colonized infants and subsequent cohorting and
contact precautions reduced the risk of MRSA
colonization in other infants by 35% [37]. Our data
suggest that while community-associated strains of
MRSA are becoming more prevalent in paediatric
ICUs, these strains are replacing other strains rather
than increasing the overall prevalence of MRSA
colonization. As CA-MRSA has been shown to be
easily transmissible between contacts, it is possible
that enhanced surveillance for and identiﬁcation of
MRSA-colonized patients has helped limit the further
spread of these strains in the ICU setting [42].
The proportion of screened children found to be
MRSA colonized remained stable over 9 years of
routine MRSA surveillance in our paediatric ICUs.
Importantly, the proportions of children colonized
with spa type 1, SCCmec type IV, or PVL-positive
strains increased signiﬁcantly over the 9-year study
period. The increasing prevalence of CA-MRSA co-
lonization in paediatric ICUs has the potential to in-
crease the risk of hospital-onset CA-MRSA infections
1990 C. R. Hermos and others
in this vulnerable population, and further research
should be performed to assess whether the frequency
of such infections is increasing.
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